JSB-Partners offers specialized investment banking and advisory services to biotechnology and pharmaceutical companies. We work closely with clients to deliver impactful business and corporate development resources and expertise. To meet their needs, we offer strategic analyses, targeted selection of and communications with potential transaction parties, proven negotiation skills, and other services needed to drive transactions to a successful closing. Our exclusive partnership with Noble Financial Capital Markets allows us to deliver a complete range of corporate finance services.
Our key types of engagements involve:
- Product Partnerships — Product partnering or licensing arrangements that provide resources and do not dilute the ownership stake held by existing shareholders
- Mergers and Acquisitions — Purchases, sales, and strategic combinations of corporate entities
- Private Placements and Public Underwritings — private financings including private investments, private investment in public equity (PIPEs) and registered direct offerings (RDOs); public underwritings – including initial public offerings (IPOs), secondary offerings and confidentially marketed public offerings (CMPOs) are provided through our exclusive partnership with Noble Life Science Partners, a division of Noble Financial Capital Markets with a history of successful financing transactions. Noble Life Science Partners also provides private funding on a principal basis through its merchant banking activities.
I have recommended the use of JSB’s services for biotechnology companies that did not have a fully developed business development department, in one case for the search of an M&A target and in the other for the out-licensing of an R&D project. I like both the well-structured approach JSB uses for the projects at hand, as well as the respect they receive from relevant companies.”— Rolf Stahel
Former CEO, Shire
JSB has extensive contacts within both the Biotech and Pharma industries and used these to rapidly identify a short list of potential partners. The process turned to M&A rather quickly and JSB is unique in that they could also serve as our M&A advisor in the transaction. They helped us run the diligence process to get to a successful sale of the assets in record time. I am pleased with their performance and would gladly use them in future projects.”— Gary Lyons
Former Chairman, NeurogesX
JSB Partners is the ideal firm for biotechnology companies to retain because of JSB’s reputation for working very closely at the beginning of an assignment with senior management and boards to precisely define the transaction that meets the client’s strategic needs. In addition, the firm is unique in its deep knowledge of the US and EU markets, having executed many cross-border transactions.”— Ken Bate
JSB employs strict process management and a professional approach. In addition, it is vital to have an independent third party advising you - not one that provides wishful thinking, but a truly realistic view. This is what sets them apart from other advisors.”— Stefan Weber